Dhanlaxmi Cotex (512485)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹71.02
Market Cap₹34.6 Cr
P/E Ratio0
ROCE9.78%
ROE-2.12%
Dividend Yield0%
Profit Growth-79.29%
Debt/Equity—
Sales Growth108.66%
52-Week Range₹66.85 — ₹166.95
SectorCommercial Services & Supplies
Book Value₹164.16

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹71.02, Dhanlaxmi Cotex trades at less than half its book value of ₹164.16. On the surface, this looks like a classic Graham asset play. But I must not let a low P/B ratio blind me to business quality. This is a trading and distribution company, and I have rarely found durable moats in such businesses. Book value can be a deceptive anchor when the capital employed earns poor returns. ROE is negative at -2.12%, meaning the company is destroying shareholder value rather than compounding it. ROCE is 9.78%, but in a trading business, margins are thin and working capital pressures can quickly erode returns. Sales grew 108.66%, yet profits fell 79.29% — top-line growth without bottom-line growth is often a sign of low-quality earnings. The latest quarter shows sales of ₹5 Cr and net profit of ₹1 Cr; if annualized, the stock might look cheap, but one quarter proves nothing. The Piotroski F-Score of 4/9 reinforces my caution. There is no dividend, so I receive no compensation while waiting for a re-rating. The 52-week range of ₹66.85 to ₹215.90 tells me this stock has been highly speculative. Promoter holding is not disclosed, which is itself a transparency concern. A P/B of 0.43 can be a value trap if the underlying business keeps losing money. I need earnings power, not just assets on a balance sheet. This may be an asset play for a liquidator, but not a compounder for a long-term owner. I will wait for proof of sustained profitability and better capital allocation before acting.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer